Clinical

Dataset Information

0

Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies


ABSTRACT: The primary purpose of this study is to see if Sym024 is safe and tolerable as monotherapy and in combination with Sym021 in patients with solid tumor malignancies.

DISEASE(S): Neoplasm Metastasis,Solid Tumor,Metastatic Cancer,Neoplasms

PROVIDER: 2361054 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2379568 | ecrin-mdr-crc
2021-12-07 | PXD017130 | Pride
2021-12-07 | PXD030220 |
| PRJNA655408 | ENA
| PRJNA882182 | ENA
| 2358872 | ecrin-mdr-crc
| PRJNA655412 | ENA
| PRJNA655410 | ENA
| PRJNA655411 | ENA
| PRJNA785139 | ENA